logo
Plus   Neg
Share
Email

Whole Foods To Cut Health-Care Benefits For 1,900 Part-time Workers

Amazon.com (AMZN) owned Whole Foods is reportedly withdrawing medical benefits for hundreds of its part-time workers starting January 1, 2020.

According to Business Insider, the changes will affect less than 2%, or 1,900 employees, of Whole Foods' workforce. Previously, employees needed to work at least 20 hours a week to qualify for the health-care plan. Now they will need to work at least 30 hours.

"In order to better meet the needs of our business and create a more equitable and efficient scheduling model, we are moving to a single-tier part-time structure," a company spokesperson said in an email.

"We are providing Team Members with resources to find alternative healthcare coverage options, or to explore full-time, healthcare-eligible positions starting at 30 hours per week. All Whole Foods Market Team Members continue to receive employment benefits including a 20% in-store discount."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
Follow RTT